
|Articles|August 22, 2018
Innovative and Robust Analytical Technologies to Address Key Challenges of Critical Quality Attributes Monitoring in Biopharmaceutical Development
Author(s)Agilent Technologies, Inc.
Advertisement
Advertisement
Advertisement
Advertisement




